AGTR1 and choroidal neovascularization: AT II promotes retinal leukostasis by activating the angiotensin type 1 receptor (AT1-R) pathway that stimulates proinflammatory, proliferative mediators, thus leading to the development and progression of PDR35 and choroidal neovascularization (CNV)36.